NYSE - Delayed Quote ? USD Teleflex Incorporated (TFX) Follow Compare 233.63 -1.99 (-0.84%) At close: October 25 at 4:00 PM EDT 233.63 0.00 (0.00%) After hours: October 25 at 5:53 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Earnings Preview: Teleflex (TFX) Q3 Earnings Expected to Decline Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Zacks ? 2 days ago TFX -0.84% PRCT TFX or EW: Which Is the Better Value Stock Right Now? TFX vs. EW: Which Stock Is the Better Value Option? Zacks ? 3 days ago EW TFX -0.84% Teleflex launches next-generation Arrow? VPS Rhythm? DLX Device?and NaviCurve? Stylet in Canada WAYNE, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the launch of two new devices in Canada designed to enhance PICC insertion procedures and reduce the chance of complications. The next-generation Arrow? VPS Rhythm? DLX Device and NaviCurve? Stylet are engineered to work together to give Vascular Access professionals more efficient and predictable PICC placement. The next-generation VPS Rhythm? DLX D GlobeNewswire ? 3 days ago TFX -0.84% New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigel? Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3) ? Barrigel? rectal spacer provides high quality rectal spacing, enabling low dose to the rectum during prostate cancer radiation therapy, with an excellent toxicity and safety profile; and low incidence (0.32-1%) of rectal wall infiltration (RWI), which can be safely reversed using hyaluronidase4,5 ? Data demonstrate safety and efficacy of Barrigel? rectal spacer in stereotactic body radiation therapy (SBRT) for patients undergoing repeat therapy6 WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Te GlobeNewswire ? 9 days ago TFX -0.84% Teleflex Announces Third Quarter 2024 Earnings Conference Call Information WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, October 31, 2024. To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website, teleflex.com. An audio replay of the call will be ava GlobeNewswire ? 9 days ago TFX -0.84% Is Teleflex Incorporated (NYSE:TFX) The Top Stock With Improving Technical Ratings According To Piper Sandler? We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where Teleflex Incorporated (NYSE:TFX) ranks among the list of stocks with improving technical rating according to Piper Sandler. The start of October has seen another wild swing for markets. September’s second half saw […] Insider Monkey ? 15 days ago TFX -0.84% Teleflex Inc (TFX) Q2 2024 Earnings Call Highlights: Strong EMEA Growth and Strategic Share ... Teleflex Inc (TFX) reports robust revenue growth in EMEA and announces a $500 million share repurchase program amidst challenges in interventional urology. GuruFocus.com ? 16 days ago TFX -0.84% TFX vs. EW: Which Stock Is the Better Value Option? TFX vs. EW: Which Stock Is the Better Value Option? Zacks ? 19 days ago EW TFX -0.84% The past three years for Teleflex (NYSE:TFX) investors has not been profitable While it may not be enough for some shareholders, we think it is good to see the Teleflex Incorporated ( NYSE:TFX... Simply Wall St. ? 27 days ago TFX -0.84% Teleflex’s Barrigel Rectal Spacer to Be Featured in Three Presentations at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting ? Highlights include new safety and efficacy data of Barrigel? rectal spacer, the first and only sculptable rectal spacer1-3 ? Teleflex to host Barrigel? Educational Symposium featuring a physician panel discussion on the Science of Personalized Spacing with Barrigel? rectal spacer WAYNE, Pa., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced three clinical studies4-6 focused on its Barrigel? rectal spacer are GlobeNewswire ? 30 days ago TFX -0.84% Teleflex? Chooses o9’s AI-Powered Platform for End-to-End Integrated Business Planning and Supply Chain Management DALLAS, September 25, 2024--o9, a leading enterprise AI software platform provider for transforming planning and decision-making, today announced that Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has selected o9 to help enhance its end-to-end integrated business planning and supply chain management capabilities. This partnership includes o9’s Demand Planning, Supply Planning, and Integrated Business Planning (IBP) technologies. Business Wire ? last month TFX -0.84% Teleflex Incorporated (TFX) Fell Despite Reporting In-Line Results Janus Henderson Investors, an investment management company, released its “Janus Henderson Contrarian Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned -1.92% in the second quarter, compared to the S&P 500? Index’s 4.28% return. Along with an accommodative monetary policy, the profits forecast for companies other […] Insider Monkey ? last month TFX -0.84% JHG TFX vs. EW: Which Stock Should Value Investors Buy Now? TFX vs. EW: Which Stock Is the Better Value Option? Zacks ? last month EW TFX -0.84% Obesity in medtech: Increased appetite for collaboration with pharma The medtech industry hopes to capitalise on increased awareness about the obesity space to promote multidisciplinary management of the disease. Medical Device Network ? last month TFX -0.84% Is Teleflex Stock a Smart Option for Your Portfolio Right Now? TFX instils optimism with its robust performance in the Interventional category and potential in Asia. Zacks ? last month TFX -0.84% BSX Veracyte (VCYT) Up 9.2% Since Last Earnings Report: Can It Continue? Veracyte (VCYT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Zacks ? last month VCYT TFX -0.84% TFX or PEN: Which Is the Better Value Stock Right Now? TFX vs. PEN: Which Stock Is the Better Value Option? Zacks ? last month TFX -0.84% Is There An Opportunity With Teleflex Incorporated's (NYSE:TFX) 40% Undervaluation? Key Insights Teleflex's estimated fair value is US$409 based on 2 Stage Free Cash Flow to Equity Teleflex's US$245... Simply Wall St. ? last month TFX -0.84% Teleflex's (TFX) Titan SGS Stapler Showcases Positive Outcomes Teleflex (TFX) publishes an analysis of clinical data showcasing the Titan SGS Stapler's enhanced clinical outcomes and significant efficiency benefits. Zacks ? last month TFX -0.84% DGX ABM Teleflex to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference WAYNE, Pa., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 22nd Annual Global Healthcare Conference at the Marriott Marquis New York, on Friday, September 6, 2024, at 7:45 a.m. (ET). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at teleflex.com. About Teleflex Incorporated As a global provider of medical technologies, T GlobeNewswire ? 2 months ago TFX -0.84% Performance Overview Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return TFX S&P 500 YTD -5.87% +21.77% 1-Year +24.02% +36.74% 3-Year -36.90% +27.79%
